911 A Novel Use of Angiotensin II Receptor Blocker (ARB) Losartan to Inhibit AOM Induced Tumorigenesis and Neoangiogenesis in Experimental Colon Cancer
Vesta Valuckaite(University of Chicago), Vani J. Konda(Baylor University Medical Center), Marc Bissonnette(University of Illinois Chicago), Sarah Ruderman(Northwestern University), Almaz Abdyrakov, Hemant K. Roy(Mymensingh Medical College Hospital), Anas Almoghrabi(John H. Stroger, Jr. Hospital of Cook County), John Hart(Center for Human Genetics), Vadim Backman(Unknown)
Cited by 6
Related Papers
Interleukin 7 receptor α chain ( IL7R ) shows allelic and functional association with multiple sclerosis
|Nature Genetics|2007|650
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis
|Carcinogenesis|2002|347
Wireless capsule endoscopy
|Gastrointestinal Endoscopy|2013|328